Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intratumoral Microbiota Impacts the First-Line Treatment Efficacy and Survival in Non-Small Cell Lung Cancer Patients Free of Lung Infection.

Journal of healthcare engineering - 1 Jan 2022

Zhang Miao, Zhang Yan, Sun Yi, Wang Shaochun, Liang Huan, Han Yaguang

Abstract excerpt

BACKGROUND: It has been known that there are microecology disorders during lung cancer development. Theoretically, intratumoral microbiota (ITM) can impact the lung cancer (LC) survival and treatment efficacy. This study conducted a follow-up investigation of non-small cell lung cancer (NSCLC) patients without lung infection to prove whether ITM indeed impacts the first-line treatment efficacy and survival....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Microbiota

Share to Mutation

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 35178229
DOI: 10.1155/2022/5466853
PMCID: PMC8844104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intratumoral Microbiota Impacts the First-Line Treatment Efficacy and Survival in Non-Small Cell Lung Cancer Patients Free of Lung Infection.PMID 35178229Read ↗

Non-small cell lung cancer microbiota characterization: Prevalence of enteric and potentially pathogenic bacteria in cancer tissuesSemantic proximity Read ↗

Gut Microbiota a Novel Source of Biomarkers for Immunotherapy in Non-small Cell Lung Cancer (NSCLC)Semantic proximity Read ↗

Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trialSemantic proximity Read ↗

The microbiome in the pathogenesis of lung cancerSemantic proximity Read ↗

The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and ProgressionSemantic proximity Read ↗

Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive reviewSemantic proximity Read ↗

Specific gut microbiome signature predicts the early-stage lung cancerSemantic proximity Read ↗

Microbiota and Small Cell Lung Cancer: A casual bystander or a hidden culprit?Semantic proximity Read ↗

The Airway Microbiota of Non-small-cell Lung Cancer Patients and its Relationship to Tumor Stage and EGFR Gene MutationSemantic proximity Read ↗

The Airway Microbiota of Non-Small-Cell Lung Cancer Patients and Its Relationship to Tumor Stage and EGFR MutationSemantic proximity Read ↗

Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut MicrobiotaSemantic proximity Read ↗

Relationship of The Lung Microbiome With PD-L1 Expression And Immunotherapy Response in Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.